Andrew Chan, M.D.

Clinical/Research Interests

Dr. Chan has extensive experience in general pulmonary and critical care medicine. His research and clinical interests are in interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis, and he directs the UC Davis ILD clinic. Dr. Chan is also involved in interventional bronchology, especially Nd:YAG laser therapy, stents, photodynamic therapy, argon plasma coagulation and cryotherapy. He is a journal reviewer for CHEST.

Title:

Associate Professor

Specialty:

Pulmonary and Critical Care, Internal Medicine

Address:

UC Davis Medical Group - Sacramento (J Street)
2825 J St., Suite 400
Sacramento, CA 95816

Education:

University of Manchester
Manchester, England
M.D. 1980

University of Manchester School of Medicine
, London
M.B./ChB. 1980

Residency:

Stanford University Hospital
Stanford, California
1991-1992
Internal Medicine

Fellowships:

UC Davis Medical Center
Sacramento, California
1987-1989
Pulmonary Critical Care Medicine

Board Certifications:

American Board of Internal Medicine, 2002
American Board of Internal Medicine, Pulmonary and Critical Care Medicine, 1995
American Board of Internal Medicine, Pulmonary Disease, 1994
American Board of Internal Medicine, 1992

Professional Memberships:

American Thoracic Society
Fellow, American College of Chest Physicians
Fellow, American College of Physicians
Fellow, Royal Society of Medicine, United Kingdom
Fellow, The Royal College of Physicians, London
Royal College of Physicians, London: Associate International Director for the Americas

Select Recent Publications:

2009 Traveline, J.M., McKenna, R. J., DeGiacomo, T., Venuta, F. , Hazelrigg, S., Boomer, M. & Criner, G. Endobronchial Valve for Persistant Air Leak Group (AL: Chan). Treatment of Persistent Pulmonary Air Leaks Using Endobronchial Valves. CHEST; American College of Chest Physicians, 136(2):355-60.

2009 T. King Jr., C. Albera, W. Bradford, U. Costabel, P. Hormel, L. Lancaster, P. Noble, S. A Sahn, J. Szwarcberg, M. Thomeer, D. Valeyre, R.M. DuBois, For the INSPIRE Study Group (A.L. Chan). Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet, DOI:10.1016/50140-67: 1.

2009 Albertson,T.E. and A.L. Chan. Antiobiotic therapy in elderly patients with acute exacerbation of chronic bronchitis. Expert Reviews in Respiratory Medicine, 3(5):539-548.

2008 Tzeng, D.Z., Leslie, K.O., Shelton, O.K., Chan, A.L. Unusual dyspnea in a woman with CREST Syndrome*. Chest, 133: 286-290. *Jointly authored

2008 Chan, AL., M.M. Juarez, R.P. Allen and T.E. Albertson. Do airway metallic stents for benign lesions confer too costly a benefit? BMC Pulmonary Medicine, 8:1-8.

2007 Strange, C., F.J.F. Herth, K.L. Kovitz, G. McLennan, A Ernst, J. Goldin, M. Noppen, J. Criner, F.C. Sciurba, VENT Study Group (AL. Chan). Design of the endobronchial valve for emphysema palliation trial (VENT): a non-surgical method of lung volume reduction. BMC Pulmonary Medicine, 7(10):1-12.

2006 Tzeng, D. and A Chan. Will patients with COPD or asthma be the next candidates? An update on advances in interventional bronchoscopy. Journal of Respiratory Diseases, 27:415-428.

2005 Tzeng, D., J. Fein, B. Nina, and A Chan. A pregnant woman with headaches, seizures, and hypertension. Lancet, 365:2150.

2005 Stoller, J.K., J. Tomashefski, Jr, R.G. Crystal, A. Arroliga, C. Strange, D.N. Killian, M.D. Schluchter, H.P. Wiedemann, for the a1-Antitrypsin Deficiency Registry Study Group (AL. Chan). Mortality in Individuals With Severe Deficiency of a 1-Antitrypsin: Findings From the National Heart, Lung, and Blood Institute Registry. Chest, 127:1196-1204.

2005 Chan, AL., M. Juarez, R. Allen, W. Volz, and T. Albertson. Pharmacokinetics and clinical effects of Mono-L-aspartyl Chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Photodermatology Photoimmunology & Photomedicine, 21:72-78.